Replies to post #16685 on Bioelectronics Corp (BIEL)

[AntiMarketMaker]

Currently, the Company's products' U.S. FDA clearance is limited to the treatment of edema following blepharoplasty (eye surgery). This additional clearance, a decision on which the Company expects over the coming weeks, will allow BioElectronics to significantly expand the addressable market opportunity.

This is where the PR went to a P and D mode. What is "coming weeks"... is it two weeks or 1000 weeks?